Caspase activation is downstream of commitment to apoptosis of Ntera-2 neuronal cells

Experimental Cell Research

Volumn 251, Issue 1, 1999, Pages 203-212

  Gibson, Rosemary M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Caspases; Clonogenic survival; Commitment; Differentiation; Neuronal apoptosis; Ntera 2

Indexed keywords

CASPASE; CASPASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL LINE; CELL STRUCTURE; CELL SURVIVAL; CLONOGENESIS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NERVE CELL; PRIORITY JOURNAL;

EID: 0033603821     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4563     Document Type: Article

References (59)

1. Oppenheim R. W. Cell death during development of the nervous system. Ann. Rev. Neurosci. 14:1991;453-501.
2. Raff M. C., Barres B. A., Burne J. F., Coles H. S., Ishizaki Y., Jacobson M. D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science. 262:1993;695-700.
3. Linnik M. D., Zobrist R. H., Hatfield M. D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 24:1993;2002-2009.
4. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
5. Stefanis L., Burke R. E., Greene L. A. Apoptosis in neurodegenerative disorders. Curr. Opin. Neurol. 10:1997;299-305.
6. McCarthy N. J., Whyte M. K. B., Gilbert C. S., Evan G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
7. Brunet C. L., Gunby R. H., Benson R. S. P., Hickman J. A., Watson A. J. M., Brady G. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ. 5:1998;107-115.
8. Amarante-Mendes G. P., Finucane D. M., Martin S. J., Cotter T. G., Salvesen G. S., Green D. R. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. 5:1998;298-306.
9. Wyllie A. H., Kerr J. F. R., Currie A. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
10. Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thornberry N. A., Wong W. W., Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
11. Thornberry N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M., Houtzager V. M., Nordstrom P. A., Roy S., Vaillancourt J. P., Chapman K. T., Nicholson D. W. A combinatorial approach defines specificities of the caspase family and granzyme B. J. Biol. Chem. 272:1997;17907-17911.
12. Nicholson D. W., Thornberry N. A. Caspases: Killer proteases. Trends Biochem. Sci. 22:1997;299-306.
13. Thornberry N. A., Lazebnik Y. Caspases: Enemies within. Science. 281:1998;1312-1316.
14. Gagliardini V., Fernandez P. A., Lee R. K. K., Drexler H. C. A., Rotello R. J., Fishman M. C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science. 263:1994;826-828.
15. Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T.-T., Yu V. L., Miller D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
16. Enari M., Hug H., Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:1995;78-81.
17. Los M., Van de Craen M., Penning L. C., Schenk H., Westendorp M., Baeuerle P. A., Droge W., Krammer P. H., Fiers W., Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature. 375:1995;81-83.
18. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
19. Samejima K., Tone S., Kottke T. J., Enari M., Sakahira H., Cooke C. A., Durrieu F., Martins L. M., Nagata S., Kaufmann S. H., Earnshaw W. C. Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution. J. Cell Biol. 143:1998;225-239.
20. Longthorne V. L., Williams G. T. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 16:1997;3805-3812.
21. Ohta T., Kinoshita T., Naito M., Nozaki T., Masutani M., Tsuruo T., Miyajima A. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J. Biol. Chem. 272:1997;23111-23116.
22. Du Y. S., Bales K. R., Dodel R. C., HamiltonByrd E., Horn J. W., Czilli D. L., Simmons L. K., Ni B. H., Paul S. M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 94:1997;11657-11662.
23. Taylor J., Gatchalian C. L., Keen G., Rubin L. L. Apoptosis in cerebellar granule neurones: Involvement of interleukin-1β converting enzyme-like proteases. J. Neurochem. 68:1997;1598-1605.
24. Postmantur R., McGinnis K., Nadimpalli R., Gilbertsen R. B., Wang K. K. W. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J. Neurochem. 68:1997;2328-2337.
25. Martinou I., Fernandez P. A., Missotten M., White E., Allet B., Sadoul R., Martinou J. C. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J. Cell Biol. 128:1995;201-208.
26. Milligan C. E., Prevette D., Yaginuma H., Homma S., Cardwell C., Fritz L. C., Tomaselli K. J., Oppenheim R. W., Schwartz L. M. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron. 15:1995;385-393.
27. Deshmukh M., Vasilakos J., Deckwerth T. L., Lampe P. A., Shivers B. D., Johnson E. M. Jr. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell Biol. 135:1996;1341-1354.
28. Loddick S. A., MacKenzie A., Rothwell N. J. An ICE inhibitor, (z)-VAD-DCB attenuates ischemic brain damage in the rat. Neuroreport. 7:1996;1465-1468.
29. Cheng Y., Deshmukh M., D'Costa A., Demaro J. A., Gidday J. M., Shah A., Sun Y., Jacquin M. F., Johnson E. M. Jr., Holtzman D. M. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101:1998;1992-1999.
30. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K. J., Yuan J., Moskowitz M. A. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18:1998;3659-3668.
31. Deshmukh M., Cheng Y., Werth J., Cocabo J., Rothman S., Holtzman D. M., Johnson E. M. Jr. Caspase inhibition: Site of action in the neuronal death pathway and therapeutic utility in ischemic brain injury. Mol. Biol. Cell. 8:1997;S351a.
32. Miller T. M., Moulder K. L., Knudson C. M., Creedon D. J., Deshmukh M., Korsmeyer S. J., Johnson E. M. Jr. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139:1997;205-217.
33. Andrews P. W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103:1984;285-293.
34. Pleasure S. J., Lee V. M.-Y. NTera 2 cells: A human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. 35:1992;585-602.
35. Kaufman S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G. Specific cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985.
36. Lazebnik Y. A., Kaufman S. H., Desnoyers S., Poirier G. G., Earnshaw W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
37. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
38. Fernandes-Alnemri T., Takahashi A., Armstrong R., Krebs J., Fritz L., Tomaselli K. J., Wang L., Yu Z., Croce C. M., Salvesen G., Earnshaw W. C., Litwack G., Alnemri E. S. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55:1995;6045-6052.
39. Talanian R. V., Quinlan C., Trautz S., Hackett M. C., Mankovich J. A., Banach D., Ghayur T., Brady K. D., Wong W. W. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:1997;9677-9682.
40. Martin S. J., O'Brien G. A., Nishioka W. K., McGahon A. J., Mahboubi A., Saido T. C., Green D. R. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270:1995;6425-6428.
41. Nath R., Raser K. J., Stafford D., Hajimohammadreza I., Posner A., Allen H., Talanian R. V., Yuen P., Gilbertsen R. B., Wang K. K. W. Non-erythroid a-spectrin breakdown by calpain and interleukin 1β-converting enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319:1996;683-690.
42. Crouch D. H., Fincham V. J., Frame M. C. Targeted proteolysis of the focal adhesion kinase pp125FAK during c-Myc-induced apoptosis is suppressed by integrin signalling. Oncogene. 12:1996;2689-2696.
43. Wen L.-P., Fahrni J. A., Troie S., Guan J.-L., Orth K., Rosen G. D. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem. 272:1998;26056-26061.
44. Gervais F. G., Thornberry N. A., Ruffolo S. C., Nicholson D. W., Roy S. Caspases cleave focal adhesion kinase (FAK) during apoptosis to generate a FRNK-like polypeptide. J. Biol. Chem. 273:1998;17102-17108.
45. Levkau B., Herren B., Koyama H., Ross R., Raines E. W. Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J. Exp. Med. 187:1998;579-586.
46. Slee E. A., Zhu H., Chow S. C., MacFarlane M., Nicholson D. W., Cohen G. M. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:1996;21-24.
47. Andrews P. W., Nudelman E., Hakomori S.-I., Fenderson B. A. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR). Differentiation. 43:1990;131-138.
48. Eisenbarth G. S., Walsh F. S., Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA. 76:1979;4913-4917.
49. Meredith J. E., Schwartz M. A. Integrins, adhesion and apoptosis. Trends Cell Biol. 7:1997;146-150.
50. Pullan S., Wilson J., Metcalfe A., Edwards G. M., Goberdhan N., Tilly J., Hickman J. A., Dive C., Streuli C. H. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci. 109:1996;631-642.
51. Bergeron L., Perez G. I., MacDonald G., Shi L., Suan Y., Jurisicova A., Varmuza S., Latham K. E., Flaws J. A., Salter J. C. M., Hara H., Moskowitz M. A., Li E., Greeberg A., Tilly J. L., Yuan J. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12:1998;1304-1314.
52. Kuida K., Zheng T. S., Na S., Kuan C.-Y., Yang D., Karasuyama H., Su M. S.-S., Rakic P., Flavell R. A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
53. Kuida K., Haydar T. F., Kuan C.-Y., Gu Y., Taya C., Karasuyama H., Su M. S.-S., Rakic P., Flavell R. A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
54. Cryns V. L., Bergeron L., Zhu H., Li H., Yuan J. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1β-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J. Biol. Chem. 271:1996;31277-31282.
55. Janicke R. U., Ng P., Spregart M. L., Porter A. G. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273:1998;15540-15545.
56. Andre E., Becker-Andre M. Expression of an N-terminally truncated form of human focal adhesion kinase in brain. Biochem. Biophys. Res. Commun. 190:1993;140-147.
57. Grant S. G. N., Karl K. A., Kiebler M. A., Kandel E. R. Focal adhesion kinase in the brain: Novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev. 9:1995;1909-1921.
58. Schaller M. D., Borgman C. A., Parsons J. T. Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol. Cell. Biol. 13:1993;785-791.
59. Birren S. J., Liching L., Andersen D. J. Sympathetic neuroblasts undergo a developmental switch in trophic dependence. Development. 119:1993;597-610.